Home › NDC Lookup › Ingredients › Acetaminophen › 51672-2114-02
Feverall Infants Acetaminophen 80 mg Suppository, 6 suppositories — NDC 51672-2114-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Feverall Infants Acetaminophen 80 mg Suppository, 6 suppositories — NDC 51672-2114-2 (Billing 51672-2114-02)

by Sun Pharmaceutical Industries, Inc. · 6 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK

This is a package of 6 suppositories of Feverall Infants Acetaminophen 80 mg Suppository from Sun Pharmaceutical Industries, Inc., marketed since Dec 2013 and currently FDA-listed; retail pharmacies pay about $0.9154 per suppositorie (NADAC). It is the main listing for this product, which comes in 2 package sizes.

NDC 51672-2114-02
🏷️ FDA NDC (as labeled) 51672-2114-2 billing pads the package segment with a zero
This package
Contains6 suppositories Cost per ea$0.9154 NADAC Per package$5.49 / 6 suppository Pack sizes2 compare ↓
Also priced by: Medicaid pays $1.36/unit — full pricing hub ↓
Main listing for product 51672-2114 · Also comes in: 50 suppositories 51672-2114-4
OTC Brand On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Sep 3, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 51672-2114-2 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
51672 labeler · 2114 product · 2 package
Package marketed since
Dec 12, 2013
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
6 EA per package
Barcode (UPC-A, from the NDC)
3 5167221142 4
Medicaid fills, this package
6,499 prescriptions in the last four reported quarters
FDA record last changed
Sep 3, 2026
⚠️
Other active recalls for Acetaminophen (different manufacturers) — 5 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Oct 21, 2025 — Defective Container (Kenvue Brands LLC) · FDA recall D-0121-2026
Class II · Aug 20, 2025 — Discoloration (Baxter Healthcare Corporation) · FDA recall D-0596-2025
Class II · May 22, 2025 — cGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets). (Aurobindo Pharma USA Inc) · FDA recall D-0471-2025
Class I · Jul 8, 2024 — Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL) (Hikma Pharmaceuticals USA Inc.) · FDA recall D-0635-2024
Class II · May 20, 2024 — Discoloration: Brownish tablets (Contract Pharmacal Corporation) · FDA recall D-0566-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 51672-2114-2
Product NDC 51672-2114
11-digit billing NDC 51672211402
NCPDP billing unit EA — each (per item)
RxCUI 198445, 209531
UNII 362O9ITL9D
Application # NDA018337
SPL Set ID 3ade895b-5dca-4d81-9415-8091923162ff
DEA schedule Non-controlled
Marketing category NDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2013-12-12
Route RECTAL
Dosage form SUPPOSITORY
Substance ACETAMINOPHEN

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 016943
GCN 16908
HICL code 001866
Ingredient (HICL) Acetaminophen
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H3
Therapeutic class — intermediate (HIC2) Analgesics
HIC3 code H3E
Therapeutic class — specific (HIC3) Analgesic/Antipyretics,Non-Salicylate
AHFS code 28:08.16.00
AHFS class Non-Opioid Analgesics
FDB label name FEVERALL 80 MG SUPPOSITORY
FDB brand name Feverall
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 016943
  • GCN: 16908
  • HICL (First Databank): 001866
  • AHFS class code: 28:08.16.00
  • RxCUI (RxNorm): 198445
Why two NDCs? The FDA registers this code as 51672-2114-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 51672-2114-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Anilides class.

Drug family (ATC) Anilides
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FEVERALL 80 MG SUPPOSITORY Ingredient Acetaminophen
📖 What it is MedlinePlus · NLM

Acetaminophen rectal is used to relieve mild to moderate pain and to reduce a fever. Acetaminophen is in a class of medications called analgesics (pain relievers) and antipyretics (fever reducers). It works by changing the way the body senses pain and by cooling the body.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves minor aches and pains, like headache, backache, toothache, muscle aches, cold aches, minor arthritis pain and menstrual cramps. It also reduces fever.
  • Follow your product label or prescriber exactly and never exceed the maximum daily amount. Remember that the limit counts every product with acetaminophen. Too much can seriously d...
  • Check the label first. Many combination products also contain acetaminophen, and you shouldn't use two together. If you aren't sure, ask me or your pharmacist.
  • Having 3 or more alcoholic drinks every day while using it raises the risk of liver damage. If you take warfarin, talk with your doctor or pharmacist first, since regular high dail...
📖 Read our full Acetaminophen guide →
1
Nutrient depletion considerations

Acetaminophen may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Acetaminophen nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.915 $5.49 / 6 suppository
Medicaid paysCMS SDUD · 12 mo $1.36 $8.14 / 6 suppository
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Feb 2024 Feb 2026 May 2026 Sep 2026 $0.931 $0.698
▲ Up 31% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
51672-2114-02 You're viewing this Main listing 6 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK $0.9154 / ea $5.49 2013-12-12 — Active
51672-2114-04 51672-2114-4 50 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK $0.6976 / ea $34.88 2013-12-12 — Active

Per ea, this pack runs about 31% above the cheapest pack (NDC 51672-2114-04, $0.6976 vs $0.9154 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 97% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package contains 6 suppositories — 6 blister pack in 1 carton / 1 suppository in 1 blister pack.
How does this package differ from NDC 51672-2114-04?
Both are Feverall Infants Acetaminophen 80 mg Suppository — the drug itself is identical. This page's package is the 6 suppositories one, while NDC 51672-2114-04 is the 50 suppositories package. Per-ea NADAC also differs: $0.9154 here vs $0.6976 for the 50 suppositories pack.
What NDC number is used to bill for this package of Feverall Infants Acetaminophen 80 mg Suppository?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Feverall Infants 80 mgthis 51672-2114-02 Sun 6 suppositories $0.915 — Availability likely —
About this product: this is the brand-name version. FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2013
On the market since
Dec 2013
📍
2026
Currently FDA-listed
13 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Acetaminophen inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 230OU9XXE4
    A waxy substance made from glycerin and stearic acid that acts as an emulsifier to blend oily and watery ingredients together. It also helps thicken and stabilize the medicine's texture.
  • UNII FM8D1RE2VP
    A plant-based oil that has been chemically hardened to stay solid at room temperature. It works as a binder and lubricant to hold tablet ingredients together and help them release properly during digestion.
  • UNII YD01N1999R
    A waxy substance made from polyethylene glycol and stearic acid. It helps mix oil and water-based ingredients together and serves as an emulsifier and solubilizer in liquid and semi-solid medicines.
  • UNII 6OZP39ZG8H
    Polysorbate 80 is a synthetic emulsifier derived from sorbitol and oleic acid. It helps mix oil and water-based ingredients together in medications and improves how the product disperses in the body.

4 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesglycerol monostearate, hydrogenated vegetable oil, polyoxyethylene stearate, polysorbate 80

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSun Pharmaceutical Industries, Inc.
Application holderTARO PHARMACEUTICAL INDUSTRIES LTD
FDA applicationNDA018337 (NDA)
Labeler code51672
First marketedDec 2013
Product typeHuman Otc Drug
Portfolio891 products on file

More NDCs from Sun Pharmaceutical Industries, Inc. labeler code 51672

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 10 words ▾

Uses temporarily reduces fever relieves minor aches, pains, and headache

⏱️ Dosage and Administration 79 words ▾

Directions this product does not contain directions or warnings for adult use do not use more than directed remove wrapper carefully insert suppository well up into the rectum Dosing Chart Age Dose under 6 months Do not use unless directed by a doctor 6 to 11 months Use 1 suppository every 6 hours (maximum of 4 doses in 24 hours) 12 to 36 months Use 1 suppository every 4 to 6 hours (maximum of 5 doses in 24 hours)

⚠️ Warnings ~1 min read ▾

Warnings Liver warning This product contains acetaminophen. Severe liver damage may occur if your child takes more than 4 doses in 24 hours, which is the maximum daily amount for ages 6 to 11 months more than 5 doses in 24 hours, which is the maximum daily amount for ages 12 to 36 months with other drugs containing acetaminophen Allergy alert: acetaminophen may cause severe skin reactions. Symptoms may include: skin reddening blisters rash If a skin reaction occurs, stop use and seek medical help right away.

For rectal use only. Do not use if you are allergic to acetaminophen. with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.

Ask a doctor before use if the child has liver disease. the child is taking the blood thinning drug warfarin. Stop use and ask a doctor if fever lasts more than 3 days (72 hours), or recurs. pain lasts more than 3 days or gets worse. new symptoms occur. redness or swelling is present in the painful area. These may be signs of a serious condition.

Keep out of reach of children. If swallowed or in case of overdose, get medical help or contact a Poison Control Center right away. Quick medical attention is critical in case of overdose for adults and for children even if you do not notice any signs or symptoms.

📦 Storage and Handling 17 words ▾

Other information store at 2°-27°C (35°-80°F) do not use if imprinted suppository wrapper is opened or damaged

🧪 Active Ingredient 10 words ▾

Active ingredient (in each rectal suppository) Acetaminophen, USP 80 mg

🧪 Inactive Ingredients 11 words ▾

Inactive ingredients glycerol monostearate, hydrogenated vegetable oil, polyoxyethylene stearate, polysorbate 80

🎯 Purpose 4 words ▾

Purposes Pain reliever/fever reducer

📄 Do Not Use 33 words ▾

Do not use if you are allergic to acetaminophen. with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.

📄 Ask a Doctor Before Use If 20 words ▾

Ask a doctor before use if the child has liver disease. the child is taking the blood thinning drug warfarin.

📄 Stop Use and Ask a Doctor If 46 words ▾

Stop use and ask a doctor if fever lasts more than 3 days (72 hours), or recurs. pain lasts more than 3 days or gets worse. new symptoms occur. redness or swelling is present in the painful area. These may be signs of a serious condition.

📄 Keep Out of Reach of Children 48 words ▾

Keep out of reach of children. If swallowed or in case of overdose, get medical help or contact a Poison Control Center right away. Quick medical attention is critical in case of overdose for adults and for children even if you do not notice any signs or symptoms.

📄 Questions or Comments 3 words ▾

Questions? call 1-866-923-4914

📄 Package Label / Principal Display Panel 25 words ▾

PRINCIPAL DISPLAY PANEL - 6 Suppository Blister Pack Carton NDC 51672-2114-2 FeverAll ® ACETAMINOPHEN SUPPOSITORIES Pain Reliever/Fever Reducer 6 Rectal Suppositories 80 mg each Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
6.5K
Units reimbursed last 4 qtrs
108.2K
Gross reimbursed last 4 qtrs
$146.9K
Avg / prescription
$22.60
Avg / unit
$1.3570
Latest quarter Q1 2026
1.9KRx
Medicaid pays / ea
$1.3570
gross reimbursed
vs
NADAC / ea
$0.9154
acquisition cost
=
Spread
+$0.4416
+48% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
68% FFS 32% MCO
Fee-for-service · 4,432 Rx Managed care · 2,067 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 1,658 units · 28.9 per 100k residents MN Wisconsin: 3,076 units · 52.0 per 100k residents WI Michigan: no data reported MI New York: 58,827 units · 301 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 455 units · 10.7 per 100k residents OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 472 units · 6.9 per 100k residents IN Ohio: 7,035 units · 59.7 per 100k residents OH Pennsylvania: 4,222 units · 32.6 per 100k residents PA New Jersey: 6,654 units · 71.6 per 100k residents NJ Massachusetts: 7,830 units · 112 per 100k residents MA California: 8,578 units · 22.0 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 2,590 units · 57.2 per 100k residents KY West Virginia: no data reported WV Virginia: 1,378 units · 15.8 per 100k residents VA Maryland: 929 units · 15.0 per 100k residents MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 1,174 units · 15.8 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: 1,299 units · 18.2 per 100k residents TN North Carolina: no data reported NC South Carolina: 428 units · 8.0 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 268 units · 2.4 per 100k residents GA D.C.: no data reported DC Hawaii: 1,352 units · 94.2 per 100k residents HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
2.4301
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 301 /100k
2 Massachusetts 112 /100k
3 Hawaii 94.2 /100k
4 New Jersey 71.6 /100k
5 Ohio 59.7 /100k
6 Kentucky 57.2 /100k
7 Wisconsin 52.0 /100k
8 Pennsylvania 32.6 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
6 suppositories this page51672-2114-02 6,499 Rx · $146,856
50 suppositories51672-2114-04 198 Rx · $4,427
Drug total (last 4 qtrs): 6,697 Rx · 112,362 units · $151,283 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Acetaminophen (matched by generic name) — the program that covers self-administered drugs. 5 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Acetaminophen. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$34K
Claims incl. refills
277
Beneficiaries
145
Spend / beneficiary
$234.25
Spend / claim
$122.62
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Feverall Infants (this brand).

Top reported reactions

Fatigue20,905
Pain18,474
Nausea18,188
Headache17,134
Toxicity To Various Agents15,890
Dyspnoea15,020
Pyrexia14,588

Reporter sex

254,186 reports
Male · 38%
Female · 62%
Unknown · 0%

Serious outcomes

Hospitalization114,602
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 28,618 12,601
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 51672-2108-01 · Sun 51672-2115-02 · Sun →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.